MedPath

Effect of adding midazolam to bupivacaine during ultrasound guided single injection rectus sheath block.

Not Applicable
Conditions
postoperative pain
Registration Number
PACTR201612001905316
Lead Sponsor
Minoufiya University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
All
Target Recruitment
60
Inclusion Criteria

Adult patients
ASA I or II
undergoing umbilical hernia repair

Exclusion Criteria

refusal of the patients to give informed consent,
pre-existing coagulation disorders (international normalized ratio > 1.5), morbid obesity (body mass index ¿ 35 kg/m2), significant cardiac, hepatic or renal disease,
local infection at the site of the block or allergy to the drug under study

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
postoperative 48 h morphine consumption
Secondary Outcome Measures
NameTimeMethod
duration of analgesia, postoperative pain, as evaluated by VAS for pain scoring at 1, 2,6, 12, 24, and 48 h postoperatively, reported nausea, vomiting, somnolence or any adverse drug reactions like pruritus, and bowel activity
© Copyright 2025. All Rights Reserved by MedPath